The downgrade from Overweight to Equal-Weight suggests that Morgan Stanley sees less upside potential for the stock, which could negatively impact the stock price. However, the increase in the price target from $38 to $45 indicates that the analyst still sees some potential for price appreciation, which could have a positive effect. The net effect is likely to be neutral in the short term.